Evidence-Based Benefits
- NAD+ restoration — a 2022 clinical trial (Yi et al.) demonstrated that 250mg NMN daily for 12 weeks significantly increased blood NAD+ levels in healthy middle-aged adults, confirming oral bioavailability in humans
- Insulin sensitivity — a randomized controlled trial by Yoshino et al. (2021) in postmenopausal women with prediabetes found that 250mg NMN daily for 10 weeks improved skeletal muscle insulin sensitivity by approximately 25%
- Muscle function and aerobic capacity — Liao et al. (2022) reported that NMN supplementation at 600-1200mg daily improved aerobic capacity and endurance in recreational runners over a 6-week period
- DNA repair and sirtuin activation — NAD+ is a required cofactor for SIRT1-SIRT7 enzymes, which regulate DNA repair, inflammation, and metabolic homeostasis; restoring NAD+ levels reactivates these pathways
- Mitochondrial health — preclinical studies consistently show NMN rescues age-related mitochondrial dysfunction, though human confirmation is ongoing